212 related articles for article (PubMed ID: 36356302)
1. A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.
Yu X; Ma H; Li B; Ji Y; Du Y; Liu S; Li Z; Hao Y; Tian S; Zhao C; Du Q; Jin Z; Zhu X; Tian Y; Chen X; Sun X; Yang C; Zhu F; Ju J; Zheng Y; Zhang W; Wang J; Yang T; Wang X; Li J; Xu X; Du S; Lu H; Ma F; Zhang H; Zhang Y; Zhang X; Hu S; He S
Blood; 2023 Mar; 141(9):1070-1086. PubMed ID: 36356302
[TBL] [Abstract][Full Text] [Related]
2. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
[TBL] [Abstract][Full Text] [Related]
3. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.
Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P
Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904
[TBL] [Abstract][Full Text] [Related]
4. MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.
Koyama M; Mukhopadhyay P; Schuster IS; Henden AS; Hülsdünker J; Varelias A; Vetizou M; Kuns RD; Robb RJ; Zhang P; Blazar BR; Thomas R; Begun J; Waddell N; Trinchieri G; Zeiser R; Clouston AD; Degli-Esposti MA; Hill GR
Immunity; 2019 Nov; 51(5):885-898.e7. PubMed ID: 31542340
[TBL] [Abstract][Full Text] [Related]
5. RIPK1 inhibitor ameliorates colitis by directly maintaining intestinal barrier homeostasis and regulating following IECs-immuno crosstalk.
Lu H; Li H; Fan C; Qi Q; Yan Y; Wu Y; Feng C; Wu B; Gao Y; Zuo J; Tang W
Biochem Pharmacol; 2020 Feb; 172():113751. PubMed ID: 31837309
[TBL] [Abstract][Full Text] [Related]
6. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation.
Wong J; Garcia-Carbonell R; Zelic M; Ho SB; Boland BS; Yao SJ; Desai SA; Das S; Planell N; Harris PA; Font-Burgada J; Taniguchi K; Bertin J; Salas A; Pasparakis M; Gough PJ; Kelliher M; Karin M; Guma M
Cell Mol Gastroenterol Hepatol; 2020; 9(2):295-312. PubMed ID: 31606566
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.
Choi J; Cooper ML; Alahmari B; Ritchey J; Collins L; Holt M; DiPersio JF
PLoS One; 2014; 9(10):e109799. PubMed ID: 25289677
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects.
Prado-Acosta M; Jeong S; Utrero-Rico A; Goncharov T; Webster JD; Holler E; Morales G; Dellepiane S; Levine JE; Rothenberg ME; Vucic D; Ferrara JLM
Sci Transl Med; 2023 Dec; 15(727):eadf8366. PubMed ID: 38117900
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis.
Roderick JE; Hermance N; Zelic M; Simmons MJ; Polykratis A; Pasparakis M; Kelliher MA
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14436-41. PubMed ID: 25246544
[TBL] [Abstract][Full Text] [Related]
10. Novel T cell/organoid culture system allows
Matthe DM; Dinkel M; Schmid B; Vogler T; Neurath MF; Poeck H; Neufert C; Büttner-Herold M; Hildner K
Front Immunol; 2023; 14():1253514. PubMed ID: 37705975
[TBL] [Abstract][Full Text] [Related]
11. Preventing necroptosis by scavenging ROS production alleviates heat stress-induced intestinal injury.
Li L; Tan H; Zou Z; Gong J; Zhou J; Peng N; Su L; Maegele M; Cai D; Gu Z
Int J Hyperthermia; 2020; 37(1):517-530. PubMed ID: 32423248
[No Abstract] [Full Text] [Related]
12. NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions.
Vlantis K; Wullaert A; Polykratis A; Kondylis V; Dannappel M; Schwarzer R; Welz P; Corona T; Walczak H; Weih F; Klein U; Kelliher M; Pasparakis M
Immunity; 2016 Mar; 44(3):553-567. PubMed ID: 26982364
[TBL] [Abstract][Full Text] [Related]
13. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
14. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
Lusthaus M; Mazkereth N; Donin N; Fishelson Z
Front Immunol; 2018; 9():306. PubMed ID: 29527209
[TBL] [Abstract][Full Text] [Related]
15. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Gab1 calibrates RIPK3-dependent necroptosis to prevent intestinal inflammation.
Xu J; Li S; Jin W; Zhou H; Zhong T; Cheng X; Fu Y; Xiao P; Cheng H; Wang D; Ke Y; Jiang Z; Zhang X
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795486
[TBL] [Abstract][Full Text] [Related]
17. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
[TBL] [Abstract][Full Text] [Related]
18. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
[TBL] [Abstract][Full Text] [Related]
19. Caspase-8, receptor-interacting protein kinase 1 (RIPK1), and RIPK3 regulate retinoic acid-induced cell differentiation and necroptosis.
Someda M; Kuroki S; Miyachi H; Tachibana M; Yonehara S
Cell Death Differ; 2020 May; 27(5):1539-1553. PubMed ID: 31659279
[TBL] [Abstract][Full Text] [Related]
20. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
